Literature DB >> 979202

Second formant transitions of selected consonant-vowel combinations in the speech of deaf and normal-hearing children.

R B Monsen.   

Abstract

Although it is well known that the speech produced by the deaf is generally of low intelligibility, the sources of this low speech intelligibility have generally been ascribed either to aberrant articulation of phonemes or inappropriate prosody. This study was designed to determine to what extent a nonsegmental aspect of speech, formant transitions, may differ in the speech of the deaf and of the normal hearing. The initial second formant transitions of the vowels /i/ and /u/ after labial and alveolar consonants (/b, d, f/) were compared in the speech of six normal-hearing and six hearing-impaired adolescents. In the speech of the hearing-impaired subjects, the second formant transitions may be reduced both in time and in frequency. At its onset, the second formant may be nearer to its eventual target frequency than in the speech of the normal subjects. Since formant transitions are important acoustic cues for the adjacent consonants, reduced F2 transitions may be an important factor in the low intelligibility of the speech of the deaf.

Entities:  

Mesh:

Year:  1976        PMID: 979202     DOI: 10.1044/jshr.1902.279

Source DB:  PubMed          Journal:  J Speech Hear Res        ISSN: 0022-4685


  3 in total

1.  An evaluation of articulatory working space area in vowel production of adults with Down syndrome.

Authors:  Kate Bunton; Mark Leddy
Journal:  Clin Linguist Phon       Date:  2010-11-22       Impact factor: 1.346

2.  Acoustic analysis of speech of cochlear implantees and its implications.

Authors:  Anjali R Kant; Rajesh Patadia; Prajakta Govale; R Rangasayee; Milind Kirtane
Journal:  Clin Exp Otorhinolaryngol       Date:  2012-04-30       Impact factor: 3.372

3.  Auditory-motor mapping training as an intervention to facilitate speech output in non-verbal children with autism: a proof of concept study.

Authors:  Catherine Y Wan; Loes Bazen; Rebecca Baars; Amanda Libenson; Lauryn Zipse; Jennifer Zuk; Andrea Norton; Gottfried Schlaug
Journal:  PLoS One       Date:  2011-09-29       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.